CDC and FDA perform multistate meningitis outbreak investigation
October 11, 2012
NORWICH – The Centers for Disease Control and Prevention, in conjunction with the Food and Drug Administration, have recently announced a multistate investigation of fungal meningitis among patients who received an epidural steroid injection with a potentially contaminated product. To date, all infected patients have received medications from three lots voluntarily recalled by the New England Compounding Center (NECC) in Framingham, Ma.
“As a precautionary measure, we’d like to inform the public that NECC is not Backus’ provider of the epidural steroid injection called into question,” said pharmacist Michael Smith, Backus Pharmacy Clinical Manager. “There is no reason to believe any Backus patients are impacted by this situation.”
Twenty three states in the nation have received the potentially contaminated medication, including Connecticut. If patients have received an epidural steroid injection since May 21, 2012, and have questions about the medication used in their procedure, they should first contact their physician. For more information, visitwww.cdc.gov/hai/outbreaks/meningitis.html.